Quidel Corporation (QDEL) Presents at ACC 2022 - Slideshow

Transaction Overview - Quidel will acquire Ortho for $24.68 per share, funded by cash and newly issued shares[33] - Ortho shareholders are expected to own approximately 38% of the combined company[33] - The transaction is expected to close in the first half of 2022[33] Financial Synergies and Outlook - The combined company anticipates long-term revenue growth of 9-11% CAGR post-COVID[33, 36] - The combined company expects an EBITDA margin greater than 30%[33, 36] - The combined company expects to achieve cost synergies of approximately $90 million and revenue synergies of over $100 million by 2025[26, 28, 33] - The combined company expects over $750 million in operating cash flow[36] Combined Company Strengths - The combined company will be a Top-7 IVD pure-play diagnostics company[16, 38] - The combined company will have a pro forma revenue of $3.9 billion based on TTM Q3 2021 results[11, 22] - The combined company will have approximately 6,000 employees worldwide[24] - Quidel has ~$925 million in cash (FY2021) and no debt[43]